Ebrahim Haroon

10.1k total citations · 3 hit papers
77 papers, 7.3k citations indexed

About

Ebrahim Haroon is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Ebrahim Haroon has authored 77 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Biological Psychiatry, 38 papers in Behavioral Neuroscience and 21 papers in Experimental and Cognitive Psychology. Recurrent topics in Ebrahim Haroon's work include Tryptophan and brain disorders (47 papers), Stress Responses and Cortisol (38 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Ebrahim Haroon is often cited by papers focused on Tryptophan and brain disorders (47 papers), Stress Responses and Cortisol (38 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Ebrahim Haroon collaborates with scholars based in United States, China and Italy. Ebrahim Haroon's co-authors include Andrew H. Miller, Charles L. Raison, Jennifer C. Felger, Bobbi J. Woolwine, Daniel Drake, Shuo Chen, Robin E. Rutherford, Pamela J. Schettler, David R. Goldsmith and Gerard Sanacora and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Pharmacological Reviews.

In The Last Decade

Ebrahim Haroon

75 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

2012 1.2k citations Bobbi J. Woolwine, Ebrahim Haroon et al. profile →
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

2011 740 citations Ebrahim Haroon, Andrew H. Miller et al. Neuropsychopharmacology profile →
CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS

2013 629 citations Andrew H. Miller, Ebrahim Haroon et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ebrahim Haroon	4.3k	3.1k	1.2k	1.2k	1.1k	77	7.3k
Jennifer C. Felger	4.0k 0.9×	3.0k 1.0×	967 0.8×	1.4k 1.1×	731 0.7×	90	6.9k
Bobbi J. Woolwine	4.4k 1.0×	3.2k 1.0×	1.1k 0.9×	1.1k 0.9×	732 0.7×	52	6.1k
Valeria Mondelli	4.2k 1.0×	3.2k 1.0×	3.5k 2.8×	895 0.7×	899 0.8×	232	10.8k
Günter Kenis	3.4k 0.8×	3.0k 1.0×	2.1k 1.7×	944 0.8×	908 0.9×	147	10.9k
Lena Brundin	2.8k 0.6×	1.8k 0.6×	916 0.7×	1.0k 0.8×	695 0.7×	94	6.2k
Golam M. Khandaker	3.9k 0.9×	2.2k 0.7×	1.6k 1.3×	721 0.6×	707 0.7×	126	6.9k
Mitchel A. Kling	1.8k 0.4×	2.9k 0.9×	1.6k 1.3×	1.2k 1.0×	549 0.5×	111	8.8k
Brian J. Miller	5.7k 1.3×	2.8k 0.9×	3.3k 2.7×	1.2k 1.0×	728 0.7×	162	10.4k
Sophie Erhardt	4.9k 1.1×	2.9k 0.9×	2.1k 1.7×	697 0.6×	344 0.3×	128	6.9k
Aye-Mu Myint	4.8k 1.1×	3.2k 1.0×	1.9k 1.6×	1.2k 1.0×	344 0.3×	74	6.9k

Countries citing papers authored by Ebrahim Haroon

Since Specialization

Citations

This map shows the geographic impact of Ebrahim Haroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebrahim Haroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebrahim Haroon more than expected).

Fields of papers citing papers by Ebrahim Haroon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebrahim Haroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebrahim Haroon. The network helps show where Ebrahim Haroon may publish in the future.

Co-authorship network of co-authors of Ebrahim Haroon

This figure shows the co-authorship network connecting the top 25 collaborators of Ebrahim Haroon. A scholar is included among the top collaborators of Ebrahim Haroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebrahim Haroon. Ebrahim Haroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldsmith, David R., Gregory P. Strauss, Robin Gross, et al.. (2025). Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia. Neuropsychopharmacology. 50(11). 1706–1714. 2 indexed citations

Treadway, Michael T., Jessica A. Cooper, Amanda R. Arulpragasam, et al.. (2024). A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation. Molecular Psychiatry. 30(4). 1407–1417. 11 indexed citations

Bekhbat, Mandakh, Zhihao Li, Michael T. Treadway, et al.. (2022). Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Molecular Psychiatry. 27(10). 4113–4121. 60 indexed citations

Bekhbat, Mandakh, David R. Goldsmith, Bobbi J. Woolwine, et al.. (2021). Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming. Molecular Psychiatry. 26(12). 7384–7392. 20 indexed citations

Su, Yun‐Ai, Jingyu Lin, Qi Liu, et al.. (2020). Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder. Journal of Psychiatric Research. 129. 53–60. 18 indexed citations

Bekhbat, Mandakh, Michael T. Treadway, David R. Goldsmith, et al.. (2020). Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia. Brain Behavior and Immunity. 88. 161–165. 56 indexed citations

Goldsmith, David R., Mandakh Bekhbat, Ngoc‐Anh Le, et al.. (2020). Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depression. Brain Behavior and Immunity. 88. 193–202. 32 indexed citations

Yin, Lijun, Xiaodan Xu, Gang Chen, et al.. (2019). Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex. Brain Behavior and Immunity. 80. 657–666. 86 indexed citations

Goldsmith, David R., Ebrahim Haroon, Andrew H. Miller, et al.. (2018). TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. Schizophrenia Research. 199. 281–284. 100 indexed citations

10.

Goldsmith, David R., Ebrahim Haroon, Andrew H. Miller, et al.. (2018). Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behavior and Immunity. 76. 268–274. 55 indexed citations

11.

Haroon, Ebrahim, Bobbi J. Woolwine, David R. Goldsmith, et al.. (2018). Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology. 95. 43–49. 215 indexed citations

12.

Haroon, Ebrahim, Xiangchuan Chen, Zhihao Li, et al.. (2018). Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia. Translational Psychiatry. 8(1). 189–189. 80 indexed citations

13.

Felger, Jennifer C., Ebrahim Haroon, Trusharth Patel, et al.. (2018). What does plasma CRP tell us about peripheral and central inflammation in depression?. Molecular Psychiatry. 25(6). 1301–1311. 317 indexed citations

14.

Goldsmith, David R., Ebrahim Haroon, Bobbi J. Woolwine, et al.. (2016). Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behavior and Immunity. 56. 281–288. 102 indexed citations

15.

Haroon, Ebrahim, Candace C. Fleischer, Jennifer C. Felger, et al.. (2016). Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Molecular Psychiatry. 21(10). 1351–1357. 184 indexed citations

16.

Miller, Andrew H., Ebrahim Haroon, & Jennifer C. Felger. (2016). Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation. Neuropsychopharmacology. 42(1). 334–359. 117 indexed citations

17.

Felger, Jennifer C., Z Li, Ebrahim Haroon, et al.. (2015). Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Molecular Psychiatry. 21(10). 1358–1365. 468 indexed citations

18.

Haroon, Ebrahim, Albert Thomas, Olusola Ajilore, et al.. (2008). Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients. Psychiatry Research Neuroimaging. 171(1). 10–19. 23 indexed citations

19.

Ajilore, Olusola, Ebrahim Haroon, S Senthil Kumaran, et al.. (2006). Measurement of Brain Metabolites in Patients with type 2 Diabetes and Major Depression Using Proton Magnetic Resonance Spectroscopy. Neuropsychopharmacology. 32(6). 1224–1231. 102 indexed citations

20.

Letamendi, Andrea, Virginia Elderkin‐Thompson, Ebrahim Haroon, et al.. (2006). Cognitive function in adults with type 2 diabetes and major depression. Archives of Clinical Neuropsychology. 21(8). 787–796. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact